Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics Analysis

Abstract

In conclusion, these pathways and genes identified could help understanding the mechanism of development of TNBC. Besides, SOX8, AR, C9orf152, NRK and RAB30, and other key genes and pathways might be promising targets for the TNBC treatment.

References

Page 1

	Year	Citations
Comprehensive molecular characterization of human colon and rectal cancer Nature MedicineColorectal CancerPathologyHuman ColonOncology	2012	8.5K
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies Brian D. Lehmann, Joshua A. Bauer, Xi Chen, Journal of Clinical Investigation Androgen ReceptorBreast OncologyTumor BiologyOncologyTumor Heterogeneity	2011	5.3K
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma Torsten O. Nielsen, Forrest D. Hsu, Kristin C. Jensen, Clinical Cancer Research	2004	2.6K
Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype Katrina Bauer, Monica Brown, Rosemary D. Cress, Cancer Breast OncologyProgesterone ReceptorEpidemiology Of CancerEstrogen ReceptorGynecology	2007	2K
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 Aron Goldhirsch, James N. Ingle, Richard D. Gelber, Annals of Oncology	2009	1.4K
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer Matthew D. Burstein, Anna Tsimelzon, Graham M. Poage, Clinical Cancer Research	2014	1.3K
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway Xi Chen, Dimitrios Iliopoulos, Qing Zhang, Nature	2014	785
Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer Ayca Gucalp, Sara M. Tolaney, Steven J. Isakoff, Clinical Cancer Research	2013	700
Incidence and Outcome of <i>BRCA</i> Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer Ana M. González-Angulo, Kirsten M. Timms, Shuying Liu, Clinical Cancer Research	2011	598
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer M. Elizabeth H. Hammond, Daniel F. Hayes, Antonio C. Wolff, Journal of Oncology Practice Evidence-based GuidelineBreast OncologyProgesterone ReceptorProgesterone ReceptorsMedicine	2010	577

Page 1